Management of complication after breast augmentation with methacrylate  by Grella, Roberto et al.
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INTRODUCTION:  Several  alloplastic  biomaterials  are  available  for  injection  to the breast,  nevertheless  not
all of  them  are  approved  for biomedical  use.  Although  in North  America  and  Western  Europe  experience
with  synthetic  biomaterials  for breast  augmentation  is  very  limited,  migratory  streams  might  expose
physicians  worldwide  to manage  the  related  complications  of  these  procedures.  The  aim  of  this  study
was to  share  with  other  surgeons  the  case  of a patient  presenting  complications  after  breast  augmentation
with  an  unknown  synthetic  substance  containing  methacrylate.
PRESENTATION  OF  CASE:  A  33-years  old  Asian  woman  presented  to our  Institution  with  breast  deformities,
lumps  and chest  pain. The  patient  referred  previous  breast  injection  “with  hospital  fat”  performed  in  China
six  years  before.  She  was  not  aware  about  the  details  of the  procedure,  and  language  barriers  limited
communication.  Clinical  examination  and  ultrasounds  revealed  the  irregular  distribution  of an  unknown
substance  in  both  breasts.  The  material  was  surgically  removed  and  replaced  in the  same  session  with
polyurethane  implants.  Chemical  analysis  revealed  the  presence  of  methacrylate.
DISCUSSION:  With  a growing  demand  for non-invasive  cosmetic  surgery,  has  been reported  a growing
population  of  untrained  and  unlicensed  personnel  performing  cosmetic  surgery  in  many  countries  where
there  are no  laws  that restrict  the  use of cosmetic  procedures  to  physicians  with  appropriate  training  and
with  approved  materials.  Surgical  removal  of  this  substances  can  be  extremely  challenging  and  an  open
procedure  with  surgical  debridement  is recommended.
CONCLUSION: Breast  augmentation  with  non-absorbable  biomaterials  can  lead  to  severe  complications,
in  particular  for  patients  intending  to breastfeed.
©  2015  Published  by Elsevier  Ltd.  on  behalf of Surgical  Associates  Ltd.  This  is an  open  access  article
he  CCunder  t
. Introduction
In recent years, breast augmentation with non-invasive
pproaches such as autologous fat grafting become more popular
1]. Several synthetic materials have been used for breast augmen-
ation, either resorbable, like hyaluronic acid [2], or non-resorbable,
ike polyacrylammide hydrogel (PAAG) [3]. However, biomaterial
njections for large volume breast augmentation are limited as they
resents several limitations involving patient safety and high costs.
Currently, many efforts have been performed in the ﬁeld of
issue engineering and regenerative medicine for the realization
f an ideal biomaterial to be used as scaffold in combination
ith stem cells for breast augmentation. Nevertheless, to date no
Abbreviations: PAAG, polyacrylammide hydrogel; SDS, sodium dodecyl sulfate;
MMA, polymethyl-methacrylate; EMA, ethyl-methacrylate; HEMA, hydroxyethyl-
ethacrylathe; FDA, food and drug administration.
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synthetic scaffold has been approved to be combined with stem
cells for breast augmentation in humans. Current techniques for
breast augmentation and reconstruction include implant position-
ing, autologous tissue transfer and fat grafting.
However, several synthetic substances are available on the mar-
ket, and not all of them are approved for medical use. The aim of
this study was  to share with other plastic surgeons the case of a
patient presenting complications after breast augmentation with
an unknown synthetic substance containing methacrylate.
2. Case presentation
A 33 years old Chinese patient came to our Institution present-
ing breast deformities, lumps, and chest pain (Fig. 1). Symptoms
started about four months before, during lactation after her ﬁrst
pregnancy. The initial manifestation was pain, swelling and right
breast leakage of a yellow material. A thorough examination of the
patient’s history revealed previous breast augmentation performed
in China six years before through bilateral breast injections with an
unknown substance. She referred several times to the procedure as
n open access article under the CC BY-NC-ND license (http://creativecommons.org/
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eig. 1. Pre-operative pictures show breast asymmetry and displaceable lumps. In 
eakage.
lipoﬁlling with hospital fat” but when asked, she afﬁrmed to have
eceived neither liposuction nor fat excision because she were too
lim. The patient was not aware about the details of the procedure,
nd language barriers further limited the communication.
On examination, breasts resulted asymmetric with irregular
ontours and visible lumps. The right breast appeared deﬂated and
maller then the left one, and presented an hyperchromic scar
bove the infra-mammary fold indicated by patient as the site
f previous breast discharge. The left breast was  larger then the
ight one, presenting edema, ﬁrmness and visible lumps. The most
oticeable was located medially, showing gel migration toward
ternal region (Fig. 1). Palpation of the right breast did not detect
ny particular sign, while in the left breasts it produced intense
ain. Under pressure palpation lumps could be displaced producing
 sense of ﬂuctuation, and the indentation persists after releasing
he pressure. Before operative procedure, the implanted material
as localized with ultrasounds.
. Surgical procedure
The patient was informed that complete removal of the sub-
tance would likely be not possible in one session, therefore she was
ncouraged to come back if symptoms would persist or represent.
n open procedure under general anesthesia was undertaken, and
urgical drainage was performed through hemi-periareolar inci-
ions. In the right breast the inﬁltrated subcutaneous and glandular
issues were dissected. In the left breast the injected substance were
ncapsulated. One capsule was excided en-block (Fig. 2) while the
ig. 2. Intra-operative pictures. In the left breast part of the injected material was
ncapsulated and excised en-block.wer quadrants of the right breast, a scar shows the previous site of methacrylate
rest of the material was  drained and squeezed out (Fig. 3). It had
a yellow, granular and semisolid aspect. After surgical removal, it
was sent to the laboratory for chemical analysis. Cavities were sub-
jected to curettage and irrigation. Immediate breast reconstruction
was performed with polyurethane prosthesis. The implant pocket
was realized in the no gel plane, and implants were placed in the
submuscular plane. Negative pressure drains were placed in both
breasts. After surgery, the patient was  invited to multiple follow-
up controls including clinical examinations and breast ecography.
Patient’s recovery was uneventful, with no recurrence during 30
months of follow-up (Fig. 4).
4. Chemical analysis
The dispersion was  centrifuged and the precipitate was sub-
jected to solubility test in organic solvents, re-suspended in acetone
and n-hexane, boiled in sodium dodecyl sulfate (SDS) in the
presence of -mercaptoethanol, and, after centrifugation, the pre-
cipitate was  treated with sulfuric acid. Chemical analysis revealed
that no protein band and peptide were detectable and that the
material had an organic nature not constituted by the silicone poly-
mer. Methacrylate was the only identiﬁed material.
5. Discussion
Over the past decades, plastic surgeons have searched for an
ideal biological or synthetic substance for breast augmentation
[4]. Several non-absorbable materials are available on the mar-
ket and few of those contain acrylates, a family of polymers
made from acrylate monomers, including acrylammide (in the
form of polyacrylammide hydrogel PAAG) or methacrylate (in the
form of polymethyl-methacrylate PMMA,  ethyl-methacrylate EMA
or hydroxyethyl-methacrylathe HEMA) [5]. Products containing
methacrylate are commercialized as ArteFill® (Suneva Medical, San
Diego, USA), Dermalive® (Dermatech, France), Metacrill® (private
lab, Rio de Janeiro, Brazil), and Rhegecoll® (Dermabiol Institute
of Kuhra Vital GmbH, Lucerne, Switzerland); among those only
ArteFill® is approved by FDA for nasolabial folds [6]. Neverthe-
less, several unapproved manufactured materials can be available
for injections in many regions like China, Latin America or Eastern
Europe, and often their components remain unknown.
To the best of our knowledge, this is the ﬁrst case report-
ing the use of methacrylate for large volume injections to the
breast: in the medical literature several studies describing breast
injection with permanent ﬁllers are available, including PAAG,
dimethylpolisiloxane (liquid silicon) and parafﬁn, but no data
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n the use of methacrylate for breast augmentation have been
reviously published. The only reported breast application of
ethacrylate consisted on small volume injections to the nipple
n order to improve its projection after breast reconstruction [7].
One of the most challenging aspects for a surgeon facing this
ohort of patients is the inability to completely remove the injected
aterial [8]. Some authors argue that permanent ﬁllers in the
reast, like PAAG, can be easily removed by aspiration with a
uction cannula [9]. Nevertheless, we considered blunt aspira-
ion extremely difﬁcult because of the semisolid consistence of
ethacrylate and also unpredictable as it might leaves residual
aterial in the breast tissues, therefore an open procedure with
urgical debridement is recommended.
The patient remained asymptomatic until she started breast-
eeding. The inﬂammation of mammary ducts during lactation in
atients with permanent ﬁllers has been previously reported after
AAG injection, and it has been postulated that the blocked lactif-
rous ducts may  lead to inﬂammation and galactocele formation
10]. Furthermore, we hypothesize that the mechanical suction
erformed by the child during lactation can cause material dis-
lacement in the breast tissue and rupture of the capsule that a yellow aspect with a granular and semisolid consistence.
surrounds it, causing material leakage and inﬂammation. There-
fore, asymptomatic patients who underwent breast injection with
permanent biomaterials should avoid breastfeeding.
6. Conclusion
Injection of synthetic non resorbable biomaterials to the breast
can causes irreversible damages, necessitating debridement proce-
dures and breast reconstruction.
With a growing demand for non-invasive cosmetic surgery, a
growing population of untrained and unlicensed personnel per-
forming cosmetic surgery has been reported in many countries
where there are no laws that restrict the use of cosmetic proce-
dures to physicians with appropriate training and with approved
materials. In North America and Western Europe experience with
non-resorbable ﬁller for breast augmentation is very limited.
However, migratory streams might expose surgeons without any
experience with these injections to manage patients with the
related complications.
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